Applied Clinical Trials
Arena Pharmaceuticals Reports Eisai's Launch of National Television...
Arena Pharmaceuticals Reports Eisai's Launch of National Television Advertising Campaign for BELVIQ? CIV for Chronic Weight Management Arena Pharmaceuticals Reports Eisai's Launch of National Television Advertising Campaign for BELVIQ CIV for Chronic Weight Management /PRNewswire/ -- Arena Pharmaceuticals, Inc. today reported that Eisai Inc. has ... (more)
Arena - Belviq Sales Up Modestly Heading Into Television Ads
It is certainly an interesting time to be an investor in Arena Pharmaceuticals .
Arena Script Sales Close Out Quarter On Positive Note
Sales of the Arena Pharmaceuticals anti-obesity drug Belviq have closed out the quarter on a positive note.
Arena Pharmaceuticals Director Donald D. Belcher Unloads 1,905 Shares
Arena Pharmaceuticals Director Donald D. Belcher sold 1,905 shares of Arena Pharmaceuticals stock in a transaction dated Tuesday, April 1st.
Insider Selling: William R. Shanahan, Jr. Unloads 60,000 Shares of Arena Pharmaceuticals Stock
Arena Pharmaceuticals SVP William R. Shanahan, Jr. unloaded 60,000 shares of the company's stock on the open market in a transaction that occurred on Tuesday, April 1st.
MannKind Doubles on FDA News, Could Drive Short Covering in Biotech Sector
You will receive a download link right in your email inbox for each of the free reports that you choose.
Arena Pharmaceuticals Sees Large Decrease in Short Interest
Arena Pharmaceuticals saw a significant decrease in short interest during the month of January.
The Motley Fool
Can Arena and VIVUS Profit From Glaxo's Troubles?
The drug remains on the shelf in Europe, where there doesn't seem to be a problem.
Momentum Indicators for Health Care Equities -- Research on Arena...
The losses were broad based as all the sectors ended the session in negative. The S&P 500 Health Care Sector Index finished the day at 686.44, down 0.37%, while the same has advanced 1.72% in the previous three trading sessions.
Arena Pharmaceuticals Sees Large Drop in Short Interest
Shares of Arena Pharmaceuticals were the recipient of a large drop in short interest during the month of January.